Objective: To assess the proportion of female childhood and adolescent tumor survivors who could benefit from oocyte cryopreservation. Design: Case series of female childhood and adolescent tumor survivors referred for fertility counseling. Setting: A referral cancer center and an infertility unit of an academic hospital. Patient(s): Young female childhood and adolescent tumor survivors who received gonadotoxic treatments. Intervention(s): Patients were prescribed tests of ovarian reserve and a personalized counseling was given. Oocyte cryopreservation was considered in subjects aged ≥18 years who were diagnosed with diminished ovarian reserve (DOR) (antimüllerian hormone level <2 ng/mL or total antral follicle count ≤10). Main Outcome Measure(s): Rate of women with DOR who stored their oocytes. Result(s): Ninety out of 126 evaluated women completed the assessments. We documented preserved ovarian reserve, DOR, and premature ovarian insufficiency in 36 (40%), 35 (39%), and 19 (21%) cases, respectively. Overall, 13 subjects with DOR were eligible for oocyte cryostorage, of whom 9 (69%) underwent the procedure. Considering the whole cohort of evaluated young women (n = 90), the rate of those who had egg freezing was 10%. Finally, nine women started seeking pregnancy after the counseling (six with DOR), and seven of them became pregnant. When the data were analyzed separately according to most gonadotoxic treatments, considerable differences emerged but the evidence did not support the idea that counseling should be restricted to particular subgroups of women. Conclusion(s): Ovarian reserve impairment is common in female childhood and adolescent tumor survivors. Postcancer oocyte cryopreservation may be part of the armamentarium of fertility preservation options.

Fertility preservation in childhood and adolescent female tumor survivors / F. Filippi, C. Meazza, E. Somigliana, M. Podda, C. Dallagiovanna, M. Massimino, F. Raspagliesi, M. Terenziani. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - 116:4(2021 Oct), pp. 1087-1095. [10.1016/j.fertnstert.2021.06.012]

Fertility preservation in childhood and adolescent female tumor survivors

E. Somigliana
;
C. Dallagiovanna;M. Terenziani
Ultimo
2021-10

Abstract

Objective: To assess the proportion of female childhood and adolescent tumor survivors who could benefit from oocyte cryopreservation. Design: Case series of female childhood and adolescent tumor survivors referred for fertility counseling. Setting: A referral cancer center and an infertility unit of an academic hospital. Patient(s): Young female childhood and adolescent tumor survivors who received gonadotoxic treatments. Intervention(s): Patients were prescribed tests of ovarian reserve and a personalized counseling was given. Oocyte cryopreservation was considered in subjects aged ≥18 years who were diagnosed with diminished ovarian reserve (DOR) (antimüllerian hormone level <2 ng/mL or total antral follicle count ≤10). Main Outcome Measure(s): Rate of women with DOR who stored their oocytes. Result(s): Ninety out of 126 evaluated women completed the assessments. We documented preserved ovarian reserve, DOR, and premature ovarian insufficiency in 36 (40%), 35 (39%), and 19 (21%) cases, respectively. Overall, 13 subjects with DOR were eligible for oocyte cryostorage, of whom 9 (69%) underwent the procedure. Considering the whole cohort of evaluated young women (n = 90), the rate of those who had egg freezing was 10%. Finally, nine women started seeking pregnancy after the counseling (six with DOR), and seven of them became pregnant. When the data were analyzed separately according to most gonadotoxic treatments, considerable differences emerged but the evidence did not support the idea that counseling should be restricted to particular subgroups of women. Conclusion(s): Ovarian reserve impairment is common in female childhood and adolescent tumor survivors. Postcancer oocyte cryopreservation may be part of the armamentarium of fertility preservation options.
Childhood tumor survivor; fertility preservation; oocyte cryopreservation; ovarian reserve; Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Counseling; Female; Humans; Infertility, Female; Neoplasms; Ovary; Primary Ovarian Insufficiency; Radiotherapy; Risk Assessment; Risk Factors; Young Adult; Cancer Survivors; Cryopreservation; Fertility Preservation; Oocyte Retrieval; Ovarian Reserve
Settore MED/40 - Ginecologia e Ostetricia
Article (author)
File in questo prodotto:
File Dimensione Formato  
Filippi et al, Completo per Air.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 273.64 kB
Formato Adobe PDF
273.64 kB Adobe PDF Visualizza/Apri
1-s2.0-S0015028221005069-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 236.42 kB
Formato Adobe PDF
236.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/890288
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact